1. Fat cells were isolated from massively obese patients at or before gastric bypass, from other patients after normalization of body weight after gastric bypass or gastroplasty (post-bypass patients) and from control subjects of a stable normal body weight.
INTRODUCTION
Although it is evident that obesity can only develop under a positive energy balance, there is much evidence that it has a strong genetic background. In a large study of adoption, the relative body weight of the adopted person was not correlated with that of the foster parents but was strongly correlated with that of the biological mother [1, 2] . It is also clear from scientific studies, everyday medical practice and common experience that although almost anybody can lose weight by dieting, this loss is practically never permanent. All this speaks for a role of metabolic factors in the development and maintenance of obesity, although the extent of their importance is not yet clear.
Lipolysis, the release of free fatty acids and glycerol from adipocytes, is stimulated by 8-adrenoceptors and inhibited by a-adrenoceptors, insulin and adenosine [3-61. Adenosine is a local effector that is released from nerve endings or formed from ATP released in this way [6] . This nucleoside has a very short half-life and therefore can only exert a local effect [6] . The response of the adipocyte to the inhibitory action of adenosine is modulated by many conditions, such as hypothyroidism [7, 8] , ageing [9] and lactation [lo] . The regulation of lipolysis is altered in morbid obesity. The concentration of free fatty acids in plasma is elevated, but by less than one would expect with the increased adipose tissue mass if the rates of lipolysis were unchanged. Indeed, turnover studies with labelled free fatty acids in plasma show that lipolysis is inhibited in viuo in obese subjects [ll] . However, fat cells isolated from obese donors have been shown to display an attenuated response to inhibitors of cyclic AMP accumulation and lipolysis, such as adenosine [l2], clonidine and prostaglandins [13] . We have recently reported that there is more adenosine in the adipose tissue of obese than in normal-weight subjects. This may explain the inhibition of lipolysis in situ and, by homologous and heterologous desensitization, the decreased inhibition by differe This could be one causing and/or maintaining o between obese and normal-we differentiate between With the good resu entration of a number of such operations in our hospitals, it has now become possible for us to investigate massively obese patients and such patients after bariatric surgery when they have reached a normal or almost normal body weight in order to determine whether alterations in adenosine sensitivity are secondary or are genetically programmed.
MATERIALS AND METHODS

Patients and subjects
Three different groups of tissue donors were studied. The massively obese group consisted of patients that underwent or were considered for a vertical banded gastroplasty or gastric bypass. The post-bypass group consisted of patients that had been massively obese but had reached a normal weight after such an operation. The post-bypass patients had lost an average of 44% of their initial body weight. The time between the operation and tissue sampling was 31.8k8.1 months and a stable body weight had been achieved. The control group consisted of subjects of a stable normal weight that had undergone routine surgery and donated a sample at that time or volunteered to give a surgical adipose tissue biopsy under local anaesthesia. Fig. 1 shows the body mass indices (weight in kg divided by the square of height in m) of the groups used in this study. The initial body mass index of the postbypass group was the same as that of the obese patients and the present body mass index was very close to that of the normal-weight control subjects. All subjects except for one in the obese group were female; their ages were 36.0k4.4, 38.4k4.5 and 45.8 k 5.5 years (means k SEM) for the normalweight, obese and post-bypass groups, respectively. One of the obese patients and one of the postbypass patients had diet-controlled type 2 diabetes; their dose-response curves were not different from those of the others in their respective groups and there was one such patient in each group so that T this fact probably did not affect the comparison of these two groups.
All samples were taken from lower abdominal subcutaneous adipose tissue.
Preparation of fat cells and studies of lipolysis
Fat samples of three subjects in each group were taken under general anaesthesia in the morning after an overnight fast. Glucose was not infused. A wedge-shaped sample of fat was removed at the beginning of the operation and placed in warm saline solution (1 50 mmol/l NaC1) for transportation to the laboratory. Since it was not possible to obtain all such samples in elective operations, the samples of two subjects in each of the three groups were taken from the lower abdominal subcutaneous adipose tissue under local anaesthesia with 1% (w/v) lignocaine.
Fat cells were isolated by a modification of the method of Rodbell [15] in the presence of collagenase (2mg/ml) under constant shaking at 2Hz at 37°C in a buffer containing 125mmol/l NaCl, 5 mmol/l KC1, 1 mmol/l CaCl,, 2.5 mmol/l MgCl,, 1 mmol/l KH,PO,, 4mmol/l glucose, 2% BSA and 25mmol/l Tris at pH 7.4. After 20min, the cells were filtered through a nylon cloth and were washed three times with the same buffer without col1agenase. Median cell diameter was estimated by direct microscopy of isolated cells. For studies of lipolysis, 1OOpl of isolated fat cells was incubated for 60min in 1 ml of the same buffer at 37°C under constant shaking at 1 Hz with the addition of adenosine deaminase (1 pg/ml) and other effectors as described below. Adenosine itself cannot be used in metabolic studies with adipocytes because it is rapidly taken up by the cells and phosphorylated or deaminated. Fat cells also release adenosine into the incubation medium, sometimes enough to cause full inhibition of lipolysis. Therefore, we added adenosine deaminase to the medium to remove endogenous adenosine and then added different concentrations of N6-(phenylisopropy1)adenosine. This analogue is neither a substrate nor an inhibitor of adenosine deaminase and cannot be phosphorylated, but it is an adenosine receptor agonist. Adenosine deaminase was dialysed against 150 mmol/l NaCl immediately before use. The incubations were terminated by adding 1 0 0~1 of 35% perchloric acid followed by centrifugation and subsequent neutralization or by boiling the samples for 2min. Glycerol was assayed spectrophotometrically or chemilumimetrically [16] . 
Statistical analysis
Factorial and two-way repeated measures analysis of variance were performed using the Macintosh StatView 512 program.
RESULTS
We have shown that the inhibitory response of adenylate cyclase to N6-(phenylisopropy1)adenosine is attenuated in fat cells [12] and in fat cell plasma membranes [14] in obesity. Therefore, it was of interest to see if this change could be reversed by weight loss. Adipocytes were isolated from the three groups of tissue donors. The volumes of the cells from obese patients, normal-weight control subjects and post-bypass patients were 913 f 197, 437 f 95 and 125 f 49 pl, respectively (means f SEM). All groups were different from the other groups (P < 0.05 by analysis of variance). Inhibition of isoprenaline-stimulated lipolysis in the three groups of isolated cells by N6-(phenylisopropy1)adenosine in the presence of exogenous adenosine deaminase is shown in Fig. 2 three groups. This allows the statistical comparison between subgroups. The difference between obese and post-bypass patients was significant at P = 0.029. Similar comparisons of stimulation of lipolysis were complicated by the fact that the mere removal of endogenous adenosine from the incubations results in variable stimulation of lipolysis. Sometimes this stimulation was close to maximal. Also, it has been reported that basal lipolysis is more active in adipocytes from obese donors. Because of these problems, unequivocally explainable data on differences in the stimulation of lipolysis between the three groups could not be obtained.
DISCUSSION
The present results suggest that the response of adipocyte lipolysis to an adenosine analogue is attenuated in obesity but is corrected by weight loss. The comparisons were made after stimulation by isoprenaline and, therefore, a difference in the stimulatory effect of this /?-adrenoceptor agonist could explain such apparent differences. However, there is plenty of evidence suggesting that this mechanism cannot be the cause of the difference in the responsiveness to adenosine. Studies with adipocytes isolated from both experimental animals [17-191 and man [20, 211 have shown a decreased re-sponsiveness to B-adrenergic stimulation of adenylate cyclase, accumulation of cyclic AMP and lipolysis in obesity. The response of palmitate turnover to infusion of adrenaline is blunted in obesity [22] . A blunted response to isoprenaline in obesity would cause a higher and not a lower responsiveness to inhibitors.
Epidemiological studies suggest that obesity has a strong genetic background, although other factors are clearly involved as well. This suggests that there may be (a) basic metabolic aberrations that lead(s) to the development and maintenance of obesity [l, 21. The reported higher adenosine content of adipose tissue in obese individuals [ 141, reflected in decreased sensitivity to adenosine in isolated cells due to a desensitization mechanism, could lead to the development and/or maintenance of obesity. The present results with adipocytes isolated from massively obese patients and such patients after reaching normal weight suggest that the difference in the sensitivity to inhibitors of lipolysis and cyclic AMP accumulation are secondary to the obesity and not due to a primary metabolic aberration that would lead to obesity. In accordance with this finding, body composition and plasma lipid concentrations of morbidly obese patients have also been reported to be normalized after weight loss [23] .
It has been speculated that the changes observed in obesity are due to the fact that fat cells from obese individuals are larger and that such larger cells have altered sensitivity to hormones [24, 25] . The present results are not necessarily in contradiction with this, but the very small cells of the post-bypass patients were no more sensitive to N6-(phenylisopropy1)adenosine than those of control subjects with the same present relative body weight. This could, of course, be explained by a non-linear correlation between cell size and responsivity and also by assuming that there is still some resistance to the nucleoside even after weight loss. However, we have reported that plasma membranes of small human fat cells are no more responsive to inhibition of adenylate cyclase than those prepared from coisolated larger fat cells of the same individual [14] . Together with this, the present results would fit better in a model where cell size per se does not regulate responsiveness.
The present results show that the attenuated inhibitory response to adenosine in fat cells isolated from obese patients is normalized by weight loss and, together with previous data, suggest that this normalization is not caused by altered cell size per se.
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